Showing results (11-20 of 215) with videos related to
Sort By:
Pageof 22
Surgery|March 1, 1993
Multiple primary melanoma: incidence and risk factors in 283 patientsC L Slingluff, R T Vollmer, H F SeiglerAnnals of Surgery|August 1, 1989
Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapyC L Slingluff, T L Darrow, H F SeiglerArchives of Surgery (Chicago, Ill. : 1960)|December 1, 1987
Human T cells specifically activated against autologous malignant melanomaC L Slingluff, T L Darrow, H F SeiglerAnnals of Plastic Surgery|January 11, 1992
Recurrent malignant melanoma: the identification of prognostic factors to predict survivalD S Reintgen, C Cox, C L Slingluff, et al.Annals of Surgery|August 1, 1988
Lethal "thin" malignant melanoma. Identifying patients at riskC L Slingluff, R T Vollmer, D S Reintgen, et al.Journal of Biological Response Modifiers|August 1, 1990
Implications of leukoregulin to autologous tumor-specific human T-cell populationsC L Slingluff, H F Seigler, T L Darrow, et al.Cancer Research|February 1, 1990
Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2-matched allogeneic melanomasN J Crowley, C L Slingluff, T L Darrow, et al.Cancer|October 11, 1992
The annual risk of melanoma progression. Implications for the concept of cureC L Slingluff, R K Dodge, W E Stanley, et al.Annals of Surgery|May 1, 1990
Malignant melanoma arising during pregnancy. A study of 100 patientsC L Slingluff, D S Reintgen, R T Vollmer, et al.Journal of the National Cancer Institute|September 7, 1988
Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive casesC L Slingluff, T Darrow, C Vervaert, et al.Pageof 22